Ultrasound-guided thrombin injection for treatment of iatrogenic femoral pseudo-aneurysm: a nursing protocol.
Femoral pseudo-aneurysm (FPA) is a pulsatile hematoma (false aneurysm) of the femoral artery that communicates with an artery through a disruption in the arterial wall. Most often, FPA develops after an injury or angiographic access to the femoral artery with bleeding into the adjacent tissue. FPA is an uncommon complication, but a very significant one, that can have serious consequences. FPA can initially present as a new thrill or bruit, a pulsatile hematoma, or marked pain and tenderness near the site of arterial puncture. Doppler flow imaging has been the mainstay of diagnosis. Ultrasound (US)-guided compression was the treatment of choice. However, it carries drawbacks including length of time to compress for adequate closure of the artery, discomfort to patients, high recurrence rate in patients receiving anticoagulation, femoral artery thrombosis, and a success rate of only 75% overall. An alternative to compression is US-guided thrombin injection (UGTI) of the FPA. This is a safe procedure that can be done as an outpatient or in an office setting. This paper will provide nursing guidelines and rationale as well as a nursing protocol for the management of patients who undergo UGTI for FPA.
North Shore LIJ/Lenox Hill Health System, New York, New York.
Victoria
V
Latessa
Theofanis
T
Fotis
D000375:Aging; D017541:Aneurysm, False / Q000000981:diagnostic imaging / Q000209:etiology / Q000451:nursing* / Q000628:therapy; D000792:Angiography / Q000009:adverse effects; D015992:Body Mass Index; D002406:Catheterization, Peripheral / Q000451:nursing*; D001026:Coronary Artery Bypass / Q000009:adverse effects; D005263:Femoral Artery / Q000000981:diagnostic imaging / Q000293:injuries / Q000601:surgery; D006490:Hemostatics / Q000008:administration & dosage*; D006801:Humans; D009730:Nursing Assessment; D009765:Obesity / Q000150:complications; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D013917:Thrombin / Q000008:administration & dosage*; D016896:Treatment Outcome; D014463:Ultrasonography
D006490:Hemostatics; D013917:Thrombin